Health Catalyst, Inc.
HCAT
$3.80
-$0.185-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.24% | 4.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.24% | 4.26% | |||
| Cost of Revenue | -7.05% | 6.23% | |||
| Gross Profit | 8.49% | 1.84% | |||
| SG&A Expenses | 5.08% | 9.16% | |||
| Depreciation & Amortization | 20.01% | 2.83% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.50% | 6.62% | |||
| Operating Income | 8.27% | -21.39% | |||
| Income Before Tax | -17.35% | -31.89% | |||
| Income Tax Expenses | -65.60% | 231.58% | |||
| Earnings from Continuing Operations | -14.85% | -40.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.85% | -40.38% | |||
| EBIT | 8.27% | -21.39% | |||
| EBITDA | 40.88% | -49.31% | |||
| EPS Basic | -4.50% | -36.04% | |||
| Normalized Basic EPS | 11.21% | -22.64% | |||
| EPS Diluted | -4.50% | -36.04% | |||
| Normalized Diluted EPS | 11.21% | -22.64% | |||
| Average Basic Shares Outstanding | 9.90% | 3.20% | |||
| Average Diluted Shares Outstanding | 9.90% | 3.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||